Xbrane Biopharma Net Income vs. Return On Asset
| XBRANE Stock | SEK 0.18 0.01 5.26% |
For Xbrane Biopharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Xbrane Biopharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Xbrane Biopharma AB utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Xbrane Biopharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Xbrane Biopharma AB over time as well as its relative position and ranking within its peers.
Xbrane |
Xbrane Biopharma Return On Asset vs. Net Income Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Xbrane Biopharma's current stock value. Our valuation model uses many indicators to compare Xbrane Biopharma value to that of its competitors to determine the firm's financial worth. Xbrane Biopharma AB is rated first in net income category among its peers. It is rated first in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Xbrane Biopharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Xbrane Biopharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Xbrane Return On Asset vs. Net Income
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Xbrane Biopharma |
| = | (188.38 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Xbrane Biopharma |
| = | -0.13 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Xbrane Return On Asset Comparison
Xbrane Biopharma is currently under evaluation in return on asset category among its peers.
Xbrane Biopharma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Xbrane Biopharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Xbrane Biopharma will eventually generate negative long term returns. The profitability progress is the general direction of Xbrane Biopharma's change in net profit over the period of time. It can combine multiple indicators of Xbrane Biopharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Xbrane Biopharma AB , a biopharmaceutical company, develops and manufactures biosimilars and generic long acting injectables. Xbrane Biopharma AB was founded in 2008 and is headquartered in Solna, Sweden. Xbrane Biopharma operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 35 people.
Xbrane Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Xbrane Biopharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Xbrane Biopharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Xbrane Biopharma's important profitability drivers and their relationship over time.
Use Xbrane Biopharma in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Xbrane Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xbrane Biopharma will appreciate offsetting losses from the drop in the long position's value.Xbrane Biopharma Pair Trading
Xbrane Biopharma AB Pair Trading Analysis
The ability to find closely correlated positions to Xbrane Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Xbrane Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Xbrane Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Xbrane Biopharma AB to buy it.
The correlation of Xbrane Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Xbrane Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Xbrane Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Xbrane Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Xbrane Biopharma position
In addition to having Xbrane Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Computers Thematic Idea Now
Computers
Companies that manufacture and distribute personal and business computers. The Computers theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Computers Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Xbrane Stock
To fully project Xbrane Biopharma's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Xbrane Biopharma at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Xbrane Biopharma's income statement, its balance sheet, and the statement of cash flows.